CL2014003317A1 - Sales de n-{4-[2,4-difluoro-3-(trifluorometil)fenil]-1,3-tiazol-2-il}-2-(1,3-dimetil-2,4-dioxo-1,2,3,4-tetrahidrotieno[2,3-d]pirimidin-5-il)acetamida; y procesos para prepararlas. - Google Patents
Sales de n-{4-[2,4-difluoro-3-(trifluorometil)fenil]-1,3-tiazol-2-il}-2-(1,3-dimetil-2,4-dioxo-1,2,3,4-tetrahidrotieno[2,3-d]pirimidin-5-il)acetamida; y procesos para prepararlas.Info
- Publication number
- CL2014003317A1 CL2014003317A1 CL2014003317A CL2014003317A CL2014003317A1 CL 2014003317 A1 CL2014003317 A1 CL 2014003317A1 CL 2014003317 A CL2014003317 A CL 2014003317A CL 2014003317 A CL2014003317 A CL 2014003317A CL 2014003317 A1 CL2014003317 A1 CL 2014003317A1
- Authority
- CL
- Chile
- Prior art keywords
- tetrahydrothiene
- thiazol
- dioxo
- pyrimidin
- difluoro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1687MU2012 | 2012-06-08 | ||
US201261665282P | 2012-06-27 | 2012-06-27 | |
IN3519MU2012 | 2012-12-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2014003317A1 true CL2014003317A1 (es) | 2015-02-13 |
Family
ID=54193746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2014003317A CL2014003317A1 (es) | 2012-06-08 | 2014-12-04 | Sales de n-{4-[2,4-difluoro-3-(trifluorometil)fenil]-1,3-tiazol-2-il}-2-(1,3-dimetil-2,4-dioxo-1,2,3,4-tetrahidrotieno[2,3-d]pirimidin-5-il)acetamida; y procesos para prepararlas. |
Country Status (22)
Country | Link |
---|---|
US (1) | US9458173B2 (es) |
EP (1) | EP2858999B1 (es) |
JP (1) | JP5989900B2 (es) |
KR (1) | KR20150015488A (es) |
CN (1) | CN104350058A (es) |
AP (1) | AP3546A (es) |
AU (1) | AU2013273118B2 (es) |
BR (1) | BR112014029155A2 (es) |
CA (1) | CA2873570C (es) |
CL (1) | CL2014003317A1 (es) |
EA (1) | EA031334B1 (es) |
HK (1) | HK1207643A1 (es) |
IL (1) | IL236084A0 (es) |
IN (1) | IN2014MN02467A (es) |
MX (1) | MX354014B (es) |
MY (1) | MY165622A (es) |
NZ (1) | NZ701721A (es) |
PE (1) | PE20142306A1 (es) |
PH (1) | PH12014502685A1 (es) |
SG (1) | SG11201408093PA (es) |
WO (1) | WO2013183035A2 (es) |
ZA (1) | ZA201500082B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR091279A1 (es) | 2012-06-08 | 2015-01-21 | Gilead Sciences Inc | Inhibidores macrociclicos de virus flaviviridae |
ES2624223T3 (es) | 2012-06-08 | 2017-07-13 | Gilead Sciences, Inc. | Inhibidores macrocíclicos de los virus flaviviridae |
CA2912578A1 (en) | 2013-06-20 | 2014-12-24 | Glenmark Pharmaceuticals S.A. | Nanoparticulate formulation comprising a trpa1 antagonist |
WO2016023832A1 (en) * | 2014-08-11 | 2016-02-18 | Hydra Biosciences, Inc. | Thieno- and furo[2,3-d]pyrimidine-2,4[1h,3h]-dione derivatives as trpc5 modulators for the treatment of neuropsychiatric disorders |
US20190175599A1 (en) * | 2014-09-16 | 2019-06-13 | Glemark Pharmaceuticals S.A. | Trpa1 antagonist for the treatment of pain associated to diabetic neuropathic pain |
TW202321229A (zh) | 2021-08-18 | 2023-06-01 | 美商富曼西公司 | 殺真菌的取代的雜環化合物 |
CN114671875A (zh) * | 2022-04-27 | 2022-06-28 | 成都施贝康生物医药科技有限公司 | 新型二氢嘧啶类化合物、异构体或盐及其制备方法和用途 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2248231A1 (de) | 1972-10-02 | 1974-04-11 | Basf Ag | 3-aminoisothiazolo eckige klammer auf 3,4-d eckige klammer zu pyrimidine |
SE9701398D0 (sv) | 1997-04-15 | 1997-04-15 | Astra Pharma Prod | Novel compounds |
ES2193839B1 (es) * | 2001-06-22 | 2005-02-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de 6-fenildihidropirrolpirimidindiona. |
AU2003253165A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidine fused bicyclic metalloproteinase inhibitors |
US6890923B2 (en) | 2002-12-16 | 2005-05-10 | Astrazeneca Ab | Compounds |
US7465581B2 (en) | 2002-12-18 | 2008-12-16 | The Scripps Research Institute | ANKTM1, a cold-activated TRP-like channel expressed in nociceptive neurons |
CA2536313A1 (en) | 2003-08-22 | 2005-03-03 | Takeda Pharmaceutical Company Limited | Fused pyrimidine derivative and use thereof |
WO2005077959A1 (en) | 2004-02-11 | 2005-08-25 | Smithkline Beecham Corporation | Pth agonists |
US20070196866A1 (en) | 2004-03-13 | 2007-08-23 | Irm Llc | Modulators of ion channel trpa1 |
WO2006083005A1 (ja) | 2005-02-03 | 2006-08-10 | Takeda Pharmaceutical Company Limited | 縮合ピリミジン誘導体およびその用途 |
US20070032531A1 (en) | 2005-08-04 | 2007-02-08 | Apogee Biotechnology Corporation | Sphingosine kinase inhibitors and methods of their use |
US20070105920A1 (en) | 2005-11-08 | 2007-05-10 | Akzo Nobel N.V. | 2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives |
AU2006327181A1 (en) | 2005-12-22 | 2007-06-28 | Hydra Biosciences, Inc. | TRPA1 inhibitors for treating pain |
TW200800997A (en) | 2006-03-22 | 2008-01-01 | Astrazeneca Ab | Chemical compounds |
CN101454318A (zh) * | 2006-03-22 | 2009-06-10 | 阿斯利康(瑞典)有限公司 | 吡啶并嘧啶衍生物及其作为pde4抑制剂的用途 |
JP2011201776A (ja) | 2008-07-23 | 2011-10-13 | Mochida Pharmaceut Co Ltd | ヘテロシクリデン−n−(3,4−ジヒドロ−2(1h)−キナゾリノン−5−イル)アセトアミド誘導体 |
CL2008000252A1 (es) | 2007-01-29 | 2008-03-14 | Xenon Pharmaceuticals Inc | Compuestos derivados de quinazolinona o pirimidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades mediadas por los canales de calcio, tales como dolor, depresion, enfermedades cardiovasculares, respir |
SI3184527T1 (sl) | 2007-06-22 | 2020-03-31 | Eli Lilly And Company | Spojine 2,6-diokso,-2,3-dihidro-1H-purina uporabne za zdravljenje stanj povezanih z aktivnostjo TRPA1 kanala |
US7951814B2 (en) * | 2008-06-17 | 2011-05-31 | Glenmark Pharmaceuticals, S.A. | Quinazolinedione derivatives as TRPA1 modulators |
WO2009158719A2 (en) | 2008-06-27 | 2009-12-30 | Hydra Biosciences, Inc. | Methods and compositions for treating disorders |
DK2411397T3 (da) | 2009-03-23 | 2013-08-05 | Glenmark Pharmaceuticals Sa | Isothiazol-pyrimidindionderivater som modulatorer af TRPA1 |
ES2456515T3 (es) | 2009-03-23 | 2014-04-22 | Glenmark Pharmaceuticals S.A. | Derivados de pirimidindiona fusionados como moduladores de TRPA1 |
US8623880B2 (en) | 2009-03-23 | 2014-01-07 | Glenmark Pharmaceuticals S.A. | Fused pyrimidine-dione derivatives as TRPA1 modulators |
PT2411395E (pt) | 2009-03-23 | 2013-06-06 | Glenmark Pharmaceuticals Sa | Derivados de furopirimidinadiona como moduladores de trpa1 |
AP3391A (en) | 2010-12-20 | 2015-08-31 | Glenmark Pharmaceuticals Sa | 2-Amino-4-arylthiazole compounds as TROA1 antagonists |
-
2013
- 2013-06-08 CA CA2873570A patent/CA2873570C/en active Active
- 2013-06-08 AU AU2013273118A patent/AU2013273118B2/en not_active Ceased
- 2013-06-08 EA EA201492054A patent/EA031334B1/ru unknown
- 2013-06-08 KR KR1020147033855A patent/KR20150015488A/ko active IP Right Grant
- 2013-06-08 NZ NZ701721A patent/NZ701721A/en not_active IP Right Cessation
- 2013-06-08 CN CN201380030184.XA patent/CN104350058A/zh active Pending
- 2013-06-08 SG SG11201408093PA patent/SG11201408093PA/en unknown
- 2013-06-08 MX MX2014014482A patent/MX354014B/es active IP Right Grant
- 2013-06-08 MY MYPI2014003389A patent/MY165622A/en unknown
- 2013-06-08 AP AP2014008076A patent/AP3546A/xx active
- 2013-06-08 WO PCT/IB2013/054703 patent/WO2013183035A2/en active Application Filing
- 2013-06-08 BR BR112014029155A patent/BR112014029155A2/pt not_active Application Discontinuation
- 2013-06-08 EP EP13742279.6A patent/EP2858999B1/en active Active
- 2013-06-08 PE PE2014002226A patent/PE20142306A1/es not_active Application Discontinuation
- 2013-06-08 US US14/402,608 patent/US9458173B2/en active Active
- 2013-06-08 JP JP2015515642A patent/JP5989900B2/ja not_active Expired - Fee Related
- 2013-06-08 IN IN2467MUN2014 patent/IN2014MN02467A/en unknown
-
2014
- 2014-12-02 PH PH12014502685A patent/PH12014502685A1/en unknown
- 2014-12-04 CL CL2014003317A patent/CL2014003317A1/es unknown
- 2014-12-04 IL IL236084A patent/IL236084A0/en unknown
-
2015
- 2015-01-07 ZA ZA2015/00082A patent/ZA201500082B/en unknown
- 2015-08-27 HK HK15108333.2A patent/HK1207643A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP2858999A2 (en) | 2015-04-15 |
EP2858999B1 (en) | 2017-05-10 |
IL236084A0 (en) | 2015-02-01 |
PH12014502685B1 (en) | 2015-01-26 |
US20150111038A1 (en) | 2015-04-23 |
ZA201500082B (en) | 2015-12-23 |
WO2013183035A2 (en) | 2013-12-12 |
IN2014MN02467A (es) | 2015-07-10 |
AP2014008076A0 (en) | 2014-11-30 |
HK1207643A1 (en) | 2016-02-05 |
BR112014029155A2 (pt) | 2017-06-27 |
US9458173B2 (en) | 2016-10-04 |
CA2873570A1 (en) | 2013-12-12 |
MX354014B (es) | 2018-02-08 |
MY165622A (en) | 2018-04-18 |
WO2013183035A3 (en) | 2014-02-27 |
AU2013273118B2 (en) | 2015-11-05 |
JP2015520183A (ja) | 2015-07-16 |
AP3546A (en) | 2016-01-14 |
CN104350058A (zh) | 2015-02-11 |
KR20150015488A (ko) | 2015-02-10 |
SG11201408093PA (en) | 2015-01-29 |
JP5989900B2 (ja) | 2016-09-07 |
PE20142306A1 (es) | 2015-01-16 |
EA201492054A1 (ru) | 2016-08-31 |
NZ701721A (en) | 2016-03-31 |
PH12014502685A1 (en) | 2015-01-26 |
EA031334B1 (ru) | 2018-12-28 |
MX2014014482A (es) | 2015-06-05 |
AU2013273118A1 (en) | 2014-11-27 |
CA2873570C (en) | 2016-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2014003317A1 (es) | Sales de n-{4-[2,4-difluoro-3-(trifluorometil)fenil]-1,3-tiazol-2-il}-2-(1,3-dimetil-2,4-dioxo-1,2,3,4-tetrahidrotieno[2,3-d]pirimidin-5-il)acetamida; y procesos para prepararlas. | |
CL2014003566A1 (es) | Compuestos derivados de 7h-pirrolo[2,3-d]pirimidinas 4-(amimo-sustituidas), inhibidores de lrrk2; composicion farmaceutica que los comprende; y metodo para tratar la enfermedad de parkinson. | |
SMT201700052B (it) | 2-(azaindol-2-il)benzimidazoli come inibitori di pad4 | |
HK1213881A1 (zh) | 作為詹納斯相關激酶 抑制劑的吡咯並 嘧啶衍生物 | |
CO6811863A2 (es) | Compuestos de 2-(2,4,5-anilino sustituido)pirimidina | |
CO6801740A2 (es) | Inhibidores de quinasa relacionados con pirrolo[2,3-d]pirimidina tropomiosina | |
IL236495A0 (en) | Heteroaromatic compounds as proton tyrosine kinase inhibitors | |
CO6910196A2 (es) | Derivados de pirrolopirimidina y purina | |
DK3808749T3 (da) | Pyrazolo[1,5-a]pyrimidiner, der er nyttige som inhibitorer af atr-kinase til behandling af kræftsygdomme | |
CO7010837A2 (es) | Compuestos derivados de 2-amino,6fenil pirido[2,3-d]pirimidina sustituidos utiles como inhibidores de quinasa raf | |
DK3415517T3 (da) | Krystallinsk form af 1-(4-1-(2,6-difluorbenzyl)-5-dimethylaminomethyl-3-(6- methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno(2,3-d)-pyrimidin- 6yl)phenyl)-3-methoxyurea | |
BR112013023156A2 (pt) | artigos para cuidados pessoais | |
LT2890680T (lt) | N-(3-fluorbenzil-2-(5-(4-morfolinofenil)piridin-2-il)acetamidas, kaip proteintirozinkinazės moduliatorius | |
EA201591939A1 (ru) | ПРОИЗВОДНЫЕ ПИРРОЛО[2,3-d]ПИРИМИДИНА В КАЧЕСТВЕ АГОНИСТОВ РЕЦЕПТОРА CB2 | |
HK1209740A1 (en) | Dioxino- and oxazin-[2,3-d]pyrimidine pi3k inhibitor compounds and methods of use --[23-d] pi3k | |
CO6811857A2 (es) | Derivados de 2-amino-3(imidazol-2-il)-piridin-4-ona, preparación de los mismos y uso terapéutico de los mismos | |
EP2754659A4 (en) | 4-SUBSTITUTED- (3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO) -PYRIMIDINES DERIVATIVES HAVING PROTEIN KINASE INHIBITION ACTIVITY AND USE THEREOF | |
CO6821957A2 (es) | Formas solidas y sales de los derivados de tetrahidro-pirido-pirimidinas | |
TH155635A (th) | เอไมด์ของสารประกอบ 2-อะมิโน-4-เอริลไธอะโซลและเกลือของสารประกอบดังกล่าว | |
TH1401003760A (th) | 2,6-ไดแฮโล-5-แอลคอกซิ-4 ซับสทิทิวเทด-พิริมิดีน, พิริมิดีน, พิริมิดีนคาร์บาลดีไฮด์, และวิธีการผลิต และการใช้ | |
TH1501001335A (th) | กระบวนการที่ปรับปรุงแล้วสำหรับการเตรียมของ 2-อะมิโน-5,8-ไดเมธอกซิ[1,2,4]ไทรอะโซโล[1,5-c]ไพริมิดีนจาก 4-อะมิโน-2,5-ไดเมธอกซิไพริมิดีน | |
UA78174U (en) | 2-(4,6-bis-ethylamino-[1,3,5]triazine-2-ylsulfanyl)-n-(2,4,6-trichlorophenyl)acetamide exhibiting antiviral activity against h1n1 virus | |
ES1077261Y (es) | Habitaculo para guardar objetos personales | |
TH130705B (th) | สมุดบันทึก | |
TH1401007889A (th) | 4-(ซับสทิทิวเทด-อะมิโน)-7H-พิร์โรโล[2,3-d]พิริมิดีนชนิดใหม่ในฐานะเป็นตัวยับยั้ง LRRK2 |